Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- AGX +21.6%, BOWL +12.4%, NX +11.6%, PATH +7.9% (also CFO to also become COO; also increases share buyback auth by $500 mln), GWRE +7.7%, ABM +7%, BRC +5.8%, IOT +5.3%, AOUT +4.3%, SMAR +4%
Other news:
- FFIE +20.3% (receives $30 million in financing commitments from the Middle East, the United States, and Asia)
- TVTX +6.7% (FDA grants full approval of FILSPARI)
- HELE +6.1% (authorizes new $500 mln share repurchase program)
- RNAC +6.1% (announces new employment inducement grant)
- BRC +5.8% (increases dividend)
- BBW +2.9% (announces deal with KC Chiefs)
- X +2.3% (CLF CEO appears on CNBC; CLF still interested in acquiring X)
- ELUT +1.7% (first-ever patient implant of EluPro)
- PFMT +1.4% (tentative award from NY state)
- GSK +1.1% (reports Phase III results for Nucala in COPD; meets primary endpoint)
- NVO +1% (to present new data from key diabetes and obesity trials at the 60th annual meeting of the European Association for the Study of Diabetes)